Published online before print November 29, 2006
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||



* Laboratory of Shock, Department of Pathophysiology, Xiangya School of Medicine, and Departments of
Pediatrics and
Rheumatology, Xiangya Hospital, Central South University, Changsha, China;
College of Optometry, University of Houston, Houston, Texas, USA; and
|| Department of Emergency Medicine, North Shore University Hospital, New York University School of Medicine, Manhasset, New York, USA
1 Correspondence: Department of Pathophysiology, Xiangya School of Medicine, Central South University, 110 Xiangya Road, Changsha, Hunan 410008, China. E-mail: xianzhongxiao{at}xysm.net
|
|
|---|
, IL-1, and IFN-
) or passively released by necrotic cells and mediates innate and adaptive inflammatory responses to infection and injury. Here, we demonstrated that a reactive oxygen species, hydrogen peroxide (H2O2), induces active and passive HMGB1 release from macrophage and monocyte cultures in a time- and dose-dependent manner. At nontoxic doses (e.g., 0.01250.125 mM), H2O2 induced HMGB1 cytoplasmic translocation and active release within 324 h. At higher concentrations (e.g., 0.25 mM), however, H2O2 exhibited cytotoxicity to macrophage and monocyte cell cultures and consequently, triggered active and passive HMGB1 release. In addition, H2O2 stimulated potential interaction of HMGB1 with a nuclear export factor, chromosome region maintenance (CRM1), in macrophage/monocyte cultures. Inhibitors specific for the JNK (SP600125) and MEK (PD98059), but not p38 MAPK (SB203580), abrogated H2O2-induced, active HMGB1 release. Together, these data establish an important role for oxidative stress in inducing active HMGB1 release, potentially through a MAPK- and CRM1-dependent mechanism.
Key Words: oxidative stress nuclear protein cytokine CRm1 MAPK
|
|
|---|
A ubiquitous nuclear protein, high-mobility group box 1 protein (HMGB1), has been established recently as a crucial mediator of lethal systemic inflammatory diseases [5
6
7
]. Residing predominantly in the nucleus of quiescent macophages/monocytes, HMGB1 can be secreted actively by macrophages/monocytes in response to exogenous and endogenous inflammatory stimuli such as endotoxin, CpG DNA, TNF-
, IL-1, and IFN-
[6
, 8
]. In addition, HMGB1 can be released passively by necrotic cells [9
]. Once released, extracellular HMGB1 mediates a wide range of biological responses in diverse cell types and tissues. In vitro, extracellular HMGB1 can activate macrophages, monocytes [10
], and promote dendritic cell (DC) maturation [11
12
13
]. In vivo, HMGB1 cause acute lung inflammation, epithelial-cell barrier leaking, and even death [14
, 15
]. Moreover, increased levels of HMGB1 are found in patients with sepsis and other major inflammatory diseases including rheumatoid arthritis [5
, 16
].
However, the potential role of oxidative stress in the regulation of HMGB1 release has not been investigated previously. These studies were therefore undertaken to determine the effects of hydrogen peroxide (H2O2)-induced oxidative stress/damage on the potential active or passive HMGB1 release in macrophage and monocyte cultures. Here, we demonstrated that H2O2 stimulates macrophages/monocytes to actively release HMGB1, potentially through a MAPK- and CRM1-dependent mechanism.
|
|
|---|
H2O2 was diluted in PBS and further diluted in culture medium. The specific MAPK inhibitors PD98059 (Promega, Madison, WI), SB203580 (Promega), and SP600125 (KangChen Biotechnology, China) were dissolved in DMSO. Cells were pretreated for 30 min with or without MAPK inhibitor prior to the addition of H2O2.
Cell viability assay
Cells were plated at a density of 104 cells/well on 96-well plates in 100 µl RPMI. Cell viability was evaluated using the conventional MTT reduction assays, where cells of each microwell were incubated with 20 µl 0.5% MTT for 2 h at 37°C, and the reaction was stopped by adding 150 µl DMSO. The amount of MTT formazan product was determined by measuring absorbance using a micro-plate reader (Bio-Rad, Hercules, CA) at a test wavelength of 570 nm and a reference wavelength of 630 nm.
Preparation of cellular extracts
At indicated time-points after the treatment, cells were harvested and washed twice with cold PBS; nuclear and cytoplasmic extracts were prepared according to the method of Schreiber et al. [17
]. Briefly, the cell pellet was resuspended in 400 µl cold buffer A (10 mM HEPES, pH 7.9, 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 1 mM DTT, 0.5 mM PMSF). The cells were allowed to swell on ice for 15 min, after which 25 µl of a 10% solution of Nonidet P-40 (NP-40) was added, and the tube was vortexed vigorously for 10 s. The homogenate was centrifuged for 30 s, and the nuclear pellet was resuspended in 50 µl ice-cold buffer B (20 mM HEPES, pH 7.9, 0.4 M NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM DTT, 1 mM PMSF). After vigorously rocking at 4°C for 15 min on a shaking platform, the nuclear extract was centrifuged for 5 min in a microfuge at 4°C, and the supernatant was frozen in aliquots at 80°C. The protein content of the different fractions was determined by a Bradford method.
Western blotting analysis
After various treatments, cell-conditioned medium was harvested and filtered through Millex-GP (Millipore, Bedford, MA) to remove cell debris and macromolecular complexes. Samples were then concentrated 40-fold with Amicon Ultra-4-10000 NMWL (Millipore) following the manufacturers instructions. Proteins in the whole-cell lysate, subcellular fractions, or concentrated cell culture supernatants were resolved on 10% SDS-PAGE gel and transferred to a polyvinylidene fluoride membrane. After blocking the membrane at room temperature for 6 h, the membrane was incubated for 2 h with various primary antibodies specific for HMGB1, chromosome region maintenance (CRM1), proliferating cell nuclear antigen (PCNA; BD Biosciences, San Jose, CA), ß-actin, and GAPDH (KangChen Biotechnology), respectively. After incubation with peroxidase-conjugated secondary antibodies for 1 h at 25°C, the signals were visualized by 3,3'-diaminobenzidine detection (Boster Biotech, China) according to the manufacturers instruction.
Immunocytochemical analysis
Cells were cultured on glass coverslips and fixed in 4% formaldehyde for 30 min at room temperature prior to detergent extraction with 0.1% Triton X-100, 10 min at 4°C. Coverslips were saturated with PBS containing 2% BSA for 1 h at room temperature and processed for immunofluorescence with anti-HMGB1 antibody (BD Biosciences), followed by Cy3-conjugated Ig (Sigma Chemical Co., St. Louis, MO) and Hoechst 33258 (Sigma Chemical Co.). Between all incubation steps, cells were washed three times for 3 min with PBS containing 0.2% BSA. Coverslips were mounted on slides using Movio (Sigma Chemical Co.). Fluorescence signals were analyzed using a fluorescence microscope (Nikon, Japan).
Coimmunoprecipitation analysis
Nuclear extracts were lysed at 4°C in ice-cold lysis buffer (50 mM Tris-HCl, pH 7.4, containing 150 mM NaCl, 1% NP-40, 0.5% Na-deoxycholate, 0.1% SDS, protease inhibitor cocktail). Lysates were cleared by centrifugation at 12,000 g for 10 min and then incubated for 2 h or overnight at 4°C with 5 µg/mL of the appropriate antibody and protein A or G agarose/sepharose beads (Amersham Biosciences, Sweden). Immune complexes were washed extensively with PBS, and proteins were eluted by boiling in 2x SDS sample buffer. Proteins were assayed by Western blotting as above.
Statistical analysis
Significance of differences between groups was determined by two-tailed Students t-test or Fishers LSD test, as indicated. P < 0.05 was considered significant.
|
|
|---|
![]() View larger version (34K): [in a new window] |
Figure 1. Effects of H2O2 on the release of HMGB1 in macrophage cultures. (A) RAW 264.7 macrophages were stimulated with H2O2 at indicated doses for 24 h, and cell viability was determined by MTT assay and expressed as mean ± SEM of four experiments in duplicate. In parallel experiments, HMGB1 levels in the whole-cell lysate (B) or culture medium (CE) were determined by the relative optical intensity [in arbitrary units (AU)] of the immunoreactive bands on Western blots and expressed as mean ± SEM of three experiments in duplicate. *, Statistically significant versus control group; P < 0.05. (D) Levels of HMGB1 in the culture medium at various time-points following stimulation with H2O2 at a nontoxic dose (0.125 mM). (E) Levels of HMGB1 in the culture medium at 24 h after the onset of a brief (for 2 h, after which H2O2 was washed out; marked as "1" or "2 h/24 h") or a persistent (for 24 h; marked as "2" or "24 h") exposure to H2O2 at indicated concentrations.
|
To gain insight into the mechanisms underlying H2O2-mediated HMGB1 release, H2O2 was washed out after a brief (2-h) exposure, and HMGB1 levels in the culture medium were determined 24 h after the onset of H2O2 stimulation. A brief exposure of macrophage cultures to H2O2 at doses nontoxic (0.125 mM) or otherwise low toxic (0.25 mM if exposed persistently) did not reduce cell viability significantly (data not shown) but triggered a marked HMGB1 release (Fig. 1E) .
H2O2 induces the translocation of HMGB1 in RAW 264.7 macrophages and human PBMCs
To determine if H2O2 induces HMGB1 cytoplasmic translocation, macrophage and monocyte cultures were immunostained with HMGB1-specific antibodies. In agreement with previous reports [18
19
20
21
], HMGB1 was noted predominantly in the nucleus of quiescent macrophages and monocytes (Fig. 2A
). At 12 h after H2O2 treatment, HMGB1 staining was observed in nuclear and cytoplasmic regions of macrophage and monocyte cultures (Fig. 2A)
. To confirm HMGB1 cytoplasmic translocation, cytoplasmic and nuclear fractions of macrophage or monocyte cultures were isolated and immunoblotted with antibodies specific for HMGB1, PCNA (a nuclear protein), or ß-actin (a cytoplasmic protein), respectively. Consistently, levels of HMGB1 in the cytoplasmic fractions were increased dramatically after treatment with H2O2 at a nontoxic concentration (0.125 mM; Fig. 2B
).
![]() View larger version (36K): [in a new window] |
Figure 2. Effects of H2O2 on HMGB1 cytoplasmic translocation in macrophage and monocyte cultures. RAW 264.7 macrophages and human PBMCs were stimulated with H2O2 at a nontoxic concentration (0.125 mM) and monitored for HMGB1 cytoplasmic translocation by immunocytochemistry (A) or cell fractionation/Western blot (B) at 12 h poststimulation (A). The relative fluorescence intensity in the nuclear ("N") or cytoplasmic ("C") regions of multiple representative cells was determined using the ImageProPlus software and expressed as mean ± SEM (in arbitrary units) of three independent experiments. Red, HMGB1; blue, nuclei; pink, Merge (original magnification, x400). (B) Following cell fractionation, HMGB1 content in the cytoplasmic ("C") or nuclear ("N") fraction was determined by Western blotting analysis. Equal loading of samples was confirmed by Western blotting analysis of each fraction with antibodies specific for a nuclear (PCNA, BD Biosciences) or cytoplasmic (ß-actin, KangChen Biotechnology) protein. Blots are representative of three independent experiments with similar results.
|
![]() View larger version (41K): [in a new window] |
Figure 3. Effects of H2O2 on CRM1 expression and interaction with HMGB1 in macrophage and monocytes cultures. RAW 264.7 macrophages and human PBMCs were stimulated with H2O2 at a nontoxic concentration (0.125 mM) for 24 h, and whole-cell lysate assayed CRM1 content by Western blotting analysis. Shown in the bar graph was the relative optical intensity (in arbitrary units) of the CRM1-immunoreactive band. A cytoplasmic housekeeping protein, GAPDH, was used as a loading control. In parallel experiments, nuclear fractions were isolated and immunoprecipitated ("IP") with CRM1- or HMGB1-specific antibodies. The precipitated proteins were subsequently immunoblotted ("IB") with CRM1- or HMGB1-specific antibodies. Blot shown is representative of three experiments with similar results.
|
![]() View larger version (35K): [in a new window] |
Figure 4. Effects of MAPK inhibitors on H2O2-induced HMGB1 translocation and release in macrophage and monocyte cultures. (A, B) RAW 264.7 macrophages were pretreated with various MAPK inhibitors [SB203580 (SB), SP600125 (SP), PD98059 (PD)] at indicated concentrations for 30 min before stimulation with H2O2 at indicated doses. At 12 h post-H2O2 stimulation, levels of HMGB1 in the culture medium (A) or cellular cytoplasmic or nuclear fractions (B) were determined by Western blotting analysis, and the relative optical intensity of HMGB1-immunoreactive band (in arbitrary units) was expressed as mean ± SEM of three experiments in duplicate. *, P < 0.05. (C) RAW 264.7 macrophages were pretreated with various MAPK inhibitors for 30 min before exposure to 0.25 mM H2O2. At 2 h post-H2O2 stimulation, H2O2 was washed out, and HMGB1 levels in the culture medium were determined at 24 h after the onset of H2O2 exposure. The relative optical intensity of HMGB1-immunoreactive band (in arbitrary units) was expressed as mean ± SEM of three experiments in duplicate. *, P < 0.05. (D) Human PBMCs (n = 5 per group) were similarly pretreated with various MAPK inhibitors (SB203580, SP600125, PD98059), at indicated concentrations for 30 min before addition of H2O2 (0.125 mM). At 6 h post-H2O2 stimulation, the levels of HMGB1 in the culture medium were assayed by Western blotting analysis and expressed as the relative optical intensity of a HMGB1-immunoreactive band (in arbitrary units). Blots are representative of three independent experiments with similar results.
|
To confirm the role of MAPKs in H2O2-induced HMGB1 release, we examined the effects of various MAPK inhibitors on H2O2-induced HMGB1 release in human monocyte cultures. Similarly, specific inhibitors for the JNK and MEK, but not p38 MAPK, significantly attenuated HMGB1 release induced by H2O2 at nontoxic doses (Fig. 4D) . Taken together, these data support a potential role for JNK and ERK, but not p38 MAPK, in H2O2-induced HMGB1 release in macrophage and monocyte cultures.
|
|
|---|
, IL-1, or IFN-
), monocytes/macrophages and pituicytes actively release HMGB1 [5
, 18
, 19
, 30
]. In addition, HMGB1 is released passively from necrotic or damaged cells [9
] and triggers an inflammatory response to injury. Extracellular HMGB1 can activate macrophages, monocytes, DC, and T cells and mediates a rigorous innate and adaptive inflammatory response to infection and injury [11
12
13
, 31
].
Although various HMGB1-inducing, inflammatory stimuli (such as LPS, TNF-
, and IFN-
) can also stimulate macrophages and monocytes to produce oxidative-free radicals, the potential role of oxidative stress (such as H2O2) in the regulation of HMGB1 release was unknown previously. Consistent with the notion that LPS and hypoxia up-regulate HMGB1 expression in vivo [29
, 32
], we found that H2O2, at non- to low toxic doses (e.g., 0.01250.25 mM), similarly increases cellular HMGB1 expression levels in macrophage cultures. It is currently unknown whether up-regulation of HMGB1 expression influences its subsequent release in response to oxidative stress.
It is more important that we demonstrated that oxidative stress could effectively stimulate macrophage/monocyte cell cultures to actively secrete HMGB1 at nontoxic doses (e.g., 0.01250.125 mM). Consistently, H2O2 induces dramatic cytoplasmic translocation of HMGB1 in macrophage and monocyte cell cultures. At higher concentrations (e.g., 0.25 mM), however, H2O2 exhibited a dose-dependent cytotoxicity and consequently, triggered a more robust release of HMGB1 as a possible result of active secretion from activated cells and passive leakage from injured cells. It is notable that a brief exposure with H2O2 was enough to induce active HMGB1 release, implicating a potential involvement of early signaling molecules (such as MAPKs) in the regulation of H2O2-induced HMGB1 release.
Various MAPKs play important roles in physiological and pathological events, including cell-cycle regulation, proliferation, apoptosis, and inflammation [2 , 33 ]. We observed that specific inhibitors for JNK (SP600125) [23 ] and MEK (PD98059) [34 ], but not for p38 MAPK (SB203580) [35 ], almost completely abrogated H2O2-induced, active HMGB1 release. The suppression of H2O2-induced HMGB1 release by JNK and MEK inhibitors was not a result of their cell toxicity, as at concentrations effectively abrogating H2O2-induced HMGB1 release, these inhibitors did not affect cell viability of macrophage cultures. Taken together, our experimental results support a potential role for JNK and ERK (but not p38) MAPKs in the regulation of H2O2-induced, HMGB1 active release.
The mechanisms underlying regulation of active HMGB1 release are complex and still remain elusive. For instance, early studies indicate that HMGB1 is secreted by macrophages/monocytes via a nonclassical, vesicle-mediated, secretory pathway [22
, 36
], but the identity of the HMGB1-containing vesicles is not yet fully characterized. Although ERK MAPK is not important in the regulation of endotoxin- or IFN-
-mediated HMGB1 release [18
, 20
], it may be important in H2O2-induced HMGB1 translocation and release. It is thus plausible that macrophages/monocytes use distinct signaling pathways to trigger HMGB1 release in response to different inflammatory stimuli.
The CRM1 protein is a leucine-rich nuclear export signal receptor involved in export of nuclear proteins [37 ] such as HMGB1 [22 ]. In the present study, we demonstrated that H2O2-induced HMGB1 release is accompanied by an increase in CRM1-HMGB1 interaction. In light of the important role of CRM1 in export of nuclear RNA and proteins [38 ], it will be important to determine whether oxidative stress induces active HMGB1 release through a CRM1-dependent mechanism in future studies.
In summary, we demonstrated here that oxidative stress such as H2O2 induces active and/or passive HMGB1 release from macrophage and monocyte cultures in a time- and dose-dependent manner. In view of the observations that specific inhibitors for JNK and ERK (but not p38) abrogated H2O2-induced HMGB1 release and that H2O2 enhanced CRM1-HMGB1 interaction significantly, we propose that oxidative stress induces active HMGB1 release in a MAPK and CRM1-dependent mechanism. Thus, it may be important to explore the therapeutic potential of many antioxidant agents in the treatment of various inflammatory diseases.
Received August 29, 2006; revised October 4, 2006; accepted November 3, 2006.
|
|
|---|
-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases Cell 120,649-661[CrossRef][Medline]
induces high mobility group box 1 protein release partly through a TNF-dependent mechanism J. Immunol. 170,3890-3897
-induced cell death in fibroblasts Proc. Natl. Acad. Sci. USA 97,5405-5410
, interleukin-1ß, -6, and high-mobility-group protein-1 in skeletal muscle Shock 19,538-546[CrossRef][Medline]
-induced apoptosis Cell 115,61-70[CrossRef][Medline]This article has been cited by other articles:
![]() |
D. Tang, R. Kang, W. Xiao, H. Zhang, M. T. Lotze, H. Wang, and X. Xiao Quercetin Prevents LPS-Induced High-Mobility Group Box 1 Release and Proinflammatory Function Am. J. Respir. Cell Mol. Biol., December 1, 2009; 41(6): 651 - 660. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Pan, J. Cardinal, R. Dhupar, M. R. Rosengart, M. T. Lotze, D. A. Geller, T. R. Billiar, and A. Tsung Low-dose cisplatin administration in murine cecal ligation and puncture prevents the systemic release of HMGB1 and attenuates lethality J. Leukoc. Biol., September 1, 2009; 86(3): 625 - 632. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Takamiya, C.-C. Hung, S. R. Hall, K. Fukunaga, T. Nagaishi, T. Maeno, C. Owen, A. A. Macias, L. E. Fredenburgh, A. Ishizaka, et al. High-Mobility Group Box 1 Contributes to Lethality of Endotoxemia in Heme Oxygenase-1-Deficient Mice Am. J. Respir. Cell Mol. Biol., August 1, 2009; 41(2): 129 - 135. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kikuchi, K.-i. Kawahara, S. Tancharoen, F. Matsuda, Y. Morimoto, T. Ito, K. K. Biswas, K. Takenouchi, N. Miura, Y. Oyama, et al. The Free Radical Scavenger Edaravone Rescues Rats from Cerebral Infarction by Attenuating the Release of High-Mobility Group Box-1 in Neuronal Cells J. Pharmacol. Exp. Ther., June 1, 2009; 329(3): 865 - 874. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Kaczorowski, K. P. Mollen, R. Edmonds, and T. R. Billiar Early events in the recognition of danger signals after tissue injury J. Leukoc. Biol., March 1, 2008; 83(3): 546 - 552. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. H. Williams and H. E. Ireland Sensing danger--Hsp72 and HMGB1 as candidate signals J. Leukoc. Biol., March 1, 2008; 83(3): 489 - 492. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Herold, B. Moser, Y. Chen, S. Zeng, S. F. Yan, R. Ramasamy, J. Emond, R. Clynes, and A. M. Schmidt Receptor for advanced glycation end products (RAGE) in a dash to the rescue: inflammatory signals gone awry in the primal response to stress J. Leukoc. Biol., August 1, 2007; 82(2): 204 - 212. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Tang, R. Kang, W. Xiao, H. Wang, S. K. Calderwood, and X. Xiao The Anti-inflammatory Effects of Heat Shock Protein 72 Involve Inhibition of High-Mobility-Group Box 1 Release and Proinflammatory Function in Macrophages J. Immunol., July 15, 2007; 179(2): 1236 - 1244. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Tang, R. Kang, W. Xiao, L. Jiang, M. Liu, Y. Shi, K. Wang, H. Wang, and X. Xiao Nuclear Heat Shock Protein 72 as a Negative Regulator of Oxidative Stress (Hydrogen Peroxide)-Induced HMGB1 Cytoplasmic Translocation and Release J. Immunol., June 1, 2007; 178(11): 7376 - 7384. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||